BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35628723)

  • 1. CRISPR/Cas9-Based Genome Editing and Its Application in
    Jin FJ; Wang BT; Wang ZD; Jin L; Han P
    J Fungi (Basel); 2022 Apr; 8(5):. PubMed ID: 35628723
    [No Abstract]   [Full Text] [Related]  

  • 2. Forced Recycling of an AMA1-Based Genome-Editing Plasmid Allows for Efficient Multiple Gene Deletion/Integration in the Industrial Filamentous Fungus
    Katayama T; Nakamura H; Zhang Y; Pascal A; Fujii W; Maruyama JI
    Appl Environ Microbiol; 2019 Feb; 85(3):. PubMed ID: 30478227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Editing Technology and Its Application Potentials in the Industrial Filamentous Fungus
    Maruyama JI
    J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436177
    [No Abstract]   [Full Text] [Related]  

  • 4. A Simple CRISPR/Cas9 System for Efficiently Targeting Genes of Aspergillus Section
    Chang PK
    Microbiol Spectr; 2023 Feb; 11(1):e0464822. PubMed ID: 36651760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Genetic Engineering Technology and Its Application in the Industrial Fungus
    Jin FJ; Hu S; Wang BT; Jin L
    Front Microbiol; 2021; 12():644404. PubMed ID: 33708187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cpf1-mediated mutagenesis and gene deletion in industrial filamentous fungi Aspergillus oryzae and Aspergillus sojae.
    Katayama T; Maruyama JI
    J Biosci Bioeng; 2022 Apr; 133(4):353-361. PubMed ID: 35101371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a genome editing technique using the CRISPR/Cas9 system in the industrial filamentous fungus Aspergillus oryzae.
    Katayama T; Tanaka Y; Okabe T; Nakamura H; Fujii W; Kitamoto K; Maruyama J
    Biotechnol Lett; 2016 Apr; 38(4):637-42. PubMed ID: 26687199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterologous and endogenous
    Zheng X; Zheng P; Sun J; Kun Z; Ma Y
    Fungal Biol Biotechnol; 2018; 5():2. PubMed ID: 29456867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
    Wang P
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome Editing in Clostridium saccharoperbutylacetonicum N1-4 with the CRISPR-Cas9 System.
    Wang S; Dong S; Wang P; Tao Y; Wang Y
    Appl Environ Microbiol; 2017 May; 83(10):. PubMed ID: 28258147
    [No Abstract]   [Full Text] [Related]  

  • 12. Progress and Challenges: Development and Implementation of CRISPR/Cas9 Technology in Filamentous Fungi.
    Wang Q; Coleman JJ
    Comput Struct Biotechnol J; 2019; 17():761-769. PubMed ID: 31312414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of microtiter plate scale CRISPR/Cas9 transformation method for
    Kuivanen J; Korja V; Holmström S; Richard P
    Fungal Biol Biotechnol; 2019; 6():3. PubMed ID: 30923622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An efficient marker-free genome editing method for
    Shen Y; Chen Z; Chen J; Zhao B; Lü J; Gui L; Lu F; Li M
    Sheng Wu Gong Cheng Xue Bao; 2022 Dec; 38(12):4744-4755. PubMed ID: 36593207
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
    Tapscott T; Guarnieri MT; Henard CA
    Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro CRISPR/Cas9 system for genome editing of Aspergillus niger based on removable bidirectional selection marker AmdS.
    Nan Y; Ouyang L; Chu J
    Biotechnol Appl Biochem; 2021 Oct; 68(5):964-970. PubMed ID: 32729961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simple and Universal System for Gene Manipulation in
    Al Abdallah Q; Ge W; Fortwendel JR
    mSphere; 2017; 2(6):. PubMed ID: 29202040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Based Editing of
    Tao W; Yang A; Deng Z; Sun Y
    Front Microbiol; 2018; 9():1660. PubMed ID: 30087666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
    Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
    Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.